Indeed, we observed a positive correlation between the level of TMEM173/STING mRNA and the IFN-I signature, as well as cancer immunogenicity-related genes (Fig. 1A), based on data retrieved from The Cancer Genome Atlas colorectal adenocarcinoma (TCGA-COAD) cohort. This evidence concerns the gene STING1 and colorectal adenocarcinoma.